Abstract
We describe the generation of a fusion cytokine consisting of GM-CSF in tandem with N-terminal-truncated MCP-1 (6-76), hereafter GMME1. Treatment of activated T cells with recombinant GMME1 protein leads to proinflammatory cytokine reduction and apoptosis via a CCR2-restricted pathway. Similarly, cell death is triggered in macrophages cultured with GMME1, while an inhibition of Ab production from plasma cells is observed. Treatment of CD4 T cells derived from experimental autoimmune encephalomyelitis mice with GMME1 leads to p38 hyperphosphorylation, inhibition of p44/42, AKT and STAT3 phosphorylation, and caspase-3 activation. GMME1 administration to experimental autoimmune encephalomyelitis mice suppresses symptomatic disease and correlates with decreased levels of inflammatory cytokines including IL-17, MOG-specific Ab titers, and blockade of CD4 and CD8 T cell infiltration in spinal cords. We propose that GMME1 defines a new class of agents for the treatment of autoimmune ailments by selectively targeting lymphomyeloid cells expressing CCR2.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acid Sequence
-
Animals
-
Apoptosis / genetics
-
Apoptosis / immunology
-
Cells, Cultured
-
Chemokine CCL2 / administration & dosage
-
Chemokine CCL2 / genetics*
-
Chemokine CCL2 / therapeutic use
-
Coculture Techniques
-
Encephalomyelitis, Autoimmune, Experimental / immunology*
-
Encephalomyelitis, Autoimmune, Experimental / pathology
-
Encephalomyelitis, Autoimmune, Experimental / therapy
-
Female
-
Granulocyte-Macrophage Colony-Stimulating Factor / administration & dosage
-
Granulocyte-Macrophage Colony-Stimulating Factor / genetics*
-
Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use
-
HeLa Cells
-
Humans
-
Lymphocytes / immunology*
-
Lymphocytes / metabolism
-
Lymphocytes / pathology
-
Mice
-
Mice, Inbred BALB C
-
Mice, Inbred C57BL
-
Mice, Knockout
-
Molecular Sequence Data
-
Myeloid Cells / immunology*
-
Myeloid Cells / metabolism
-
Myeloid Cells / pathology
-
Receptors, CCR2 / antagonists & inhibitors*
-
Receptors, CCR2 / biosynthesis
-
Receptors, CCR2 / deficiency
-
Receptors, CCR2 / genetics*
-
Recombinant Fusion Proteins / administration & dosage
-
Recombinant Fusion Proteins / chemical synthesis
-
Recombinant Fusion Proteins / physiology*
Substances
-
Ccl2 protein, mouse
-
Ccr2 protein, mouse
-
Chemokine CCL2
-
Receptors, CCR2
-
Recombinant Fusion Proteins
-
Granulocyte-Macrophage Colony-Stimulating Factor